Insider · CIK 0001758247

ANDERSON ELIZABETH M

Reports to the SEC for 3 companies · REDWOOD CITY, CA

sec.gov

Transactions

Companies

Filings

CIK

0001758247

Forms 4 and 5

Insider transactions

47 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-22	RVMDRevolution Medicines, Inc.S Sale	Director	SSale	−910 sh	$191.85	−$175K	13,566
2026-09-22	RVMDRevolution Medicines, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−5,070 sh	—	—	1,095
2026-09-22	RVMDRevolution Medicines, Inc.S Sale	Director	SSale	−100 sh	$195.15	−$19.5K	4,333
2026-09-22	RVMDRevolution Medicines, Inc.S Sale	Director	SSale	−1,500 sh	$194.59	−$292K	4,433
2026-09-22	RVMDRevolution Medicines, Inc.S Sale	Director	SSale	−2,648 sh	$193.44	−$512K	5,933
2026-09-22	RVMDRevolution Medicines, Inc.S Sale	Director	SSale	−4,985 sh	$192.54	−$960K	8,581
2026-09-22	RVMDRevolution Medicines, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+5,070 sh	$1.12	+$5,678.4	14,476
2026-06-18	RVMDRevolution Medicines, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+3,127 sh	—	—	3,127
2026-06-18	RVMDRevolution Medicines, Inc.A Award	Director	AAward	+1,191 sh	—	—	9,406
2026-06-02	BMRNBIOMARIN PHARMACEUTICAL INCA Award	Director	AAward	+7,490 sh	—	—	41,940
2026-05-13	INSMINSMED IncA Award	Director	AAward	+3,305 sh	—	—	62,034
2026-03-04	RVMDRevolution Medicines, Inc.G Gift	Director	GGift	+15K sh	—	—	15,000
2026-03-04	RVMDRevolution Medicines, Inc.G Gift	Director	GGift	−15K sh	—	—	8,215
2025-11-24	INSMINSMED IncS Sale	Director	SSale	−5,000 sh	$204.58	−$1.02M	58,729
2025-11-14	INSMINSMED IncS Sale	Director	SSale	−10K sh	$195.87	−$1.96M	63,729
2025-06-26	RVMDRevolution Medicines, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+11.6K sh	—	—	11,574
2025-06-26	RVMDRevolution Medicines, Inc.A Award	Director	AAward	+3,142 sh	—	—	23,215
2025-05-20	BMRNBIOMARIN PHARMACEUTICAL INCA Award	Director	AAward	+6,650 sh	—	—	34,450
2025-05-15	INSMINSMED IncA Award	Director	AAward	+5,058 sh	—	—	73,729
2024-06-20	RVMDRevolution Medicines, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+16.7K sh	—	—	16,700
2024-06-20	RVMDRevolution Medicines, Inc.A Award	Director	AAward	+4,248 sh	—	—	20,073
2024-06-20	RVMDRevolution Medicines, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+16K sh	—	—	15,955
2024-06-20	RVMDRevolution Medicines, Inc.A Award	Director	AAward	+4,800 sh	—	—	20,625
2024-05-21	BMRNBIOMARIN PHARMACEUTICAL INCA Award	Director	AAward	+4,720 sh	—	—	27,800
2024-05-13	INSMINSMED IncA Award	Director	AAward	+13.2K sh	—	—	68,671
2023-06-08	RVMDRevolution Medicines, Inc.A Award	Director	AAward	+5,200 sh	—	—	15,825
2023-06-08	RVMDRevolution Medicines, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+18.4K sh	—	—	18,400
2023-05-23	BMRNBIOMARIN PHARMACEUTICAL INCA Award	Director	AAward	+4,190 sh	—	—	23,080
2023-05-11	INSMINSMED IncA Award	Director	AAward	+13.2K sh	—	—	55,509
2022-06-16	RVMDRevolution Medicines, Inc.A Award	Director	AAward	+5,200 sh	—	—	10,625
2022-06-16	RVMDRevolution Medicines, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+18.4K sh	—	—	18,400
2022-05-24	BMRNBIOMARIN PHARMACEUTICAL INCA Award	Director	AAward	+4,980 sh	—	—	18,890
2022-05-11	INSMINSMED IncA Award	Director	AAward	+14.6K sh	—	—	42,317
2021-06-22	RVMDRevolution Medicines, Inc.A Award	Director	AAward	+3,617 sh	—	—	5,425
2021-06-22	RVMDRevolution Medicines, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+12.7K sh	—	—	12,659
2021-05-25	BMRNBIOMARIN PHARMACEUTICAL INCA Award	Director	AAward	+5,120 sh	—	—	13,910
2021-05-12	INSMINSMED IncA Award	Director	AAward	+7,558 sh	—	—	27,672
2020-10-15	RVMDRevolution Medicines, Inc.S Sale	Director	SSale	−4,780 sh	$45.00	−$215K	26,990
2020-10-13	RVMDRevolution Medicines, Inc.S Sale	Director	SSale	−220 sh	$45.00	−$9,900	31,770
2020-10-06	RVMDRevolution Medicines, Inc.S Sale	Director	SSale	−5,000 sh	$40.00	−$200K	31,990
2020-06-17	RVMDRevolution Medicines, Inc.A Award	Director	AAward	+1,808 sh	—	—	1,808
2020-06-17	RVMDRevolution Medicines, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+6,329 sh	—	—	6,329
2020-05-27	BMRNBIOMARIN PHARMACEUTICAL INCA Award	Director	AAward	+4,300 sh	—	—	8,790
2020-05-12	INSMINSMED IncA Award	Director	AAward	+8,097 sh	—	—	20,114
2019-07-09	BMRNBIOMARIN PHARMACEUTICAL INCA Award	Director	AAward	+4,490 sh	—	—	4,490
2019-05-15	INSMINSMED IncA Award	Director	AAward	+6,899 sh	—	—	12,017
2018-11-06	INSMINSMED IncA Award	Director	AAward	+5,118 sh	—	—	5,118

Recent filings

Accepted (ET)
Sep 244
ANDERSON ELIZABETH M0001758247-26-000004
SEC(opens sec.gov)
Jun 234
ANDERSON ELIZABETH M0001610717-26-000287
SEC(opens sec.gov)
Jun 44
ANDERSON ELIZABETH M0001628280-26-040903
SEC(opens sec.gov)
May 154
ANDERSON ELIZABETH M0001758247-26-000002
SEC(opens sec.gov)
Mar 64
ANDERSON ELIZABETH M0001610717-26-000087
SEC(opens sec.gov)
Nov 264
ANDERSON ELIZABETH M0001758247-25-000006
SEC(opens sec.gov)
Nov 184
ANDERSON ELIZABETH M0001758247-25-000004
SEC(opens sec.gov)
Jun 304
ANDERSON ELIZABETH M0001610717-25-000268
SEC(opens sec.gov)
May 224
ANDERSON ELIZABETH M0001048477-25-000062
SEC(opens sec.gov)
May 194
ANDERSON ELIZABETH M0001628280-25-026565
SEC(opens sec.gov)
Jun 284/A
ANDERSON ELIZABETH M0001610717-24-000379
SEC(opens sec.gov)

Companies

Address

C/O REVOLUTION MEDICINES, INC. 700 SAGINAW DRIVE

REDWOOD CITY, CA, 94063